Dr. Min Zhang | Nephrology | Best Researcher Award

 Cutting-Edge Research:

  • Dr. Zhang is at the forefront of nephrology research, focusing on disease mechanisms using multi-omics technology. Her ongoing projects, funded by major institutions like the National Natural Science Foundation of China, demonstrate her capability to secure competitive grants and her engagement with high-impact research.
Dr. Min Zhang, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Min Zhang began her academic journey at the prestigious Tongji Medical College of Huazhong University of Science and Technology, where she earned her bachelor’s degree. She later pursued her doctoral studies at the Academy of Military Sciences, focusing on leveraging multi-omics technology to explore disease mechanisms. Her exemplary work earned her the Outstanding Doctoral Dissertation of the PLA award, a mark of distinction that set the foundation for her impactful career.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving as an Attending Physician in the Department of Nephrology at the First Medical Center of Chinese PLA General Hospital, Dr. Zhang is committed to advancing nephrology and disease research through innovative approaches like single-cell sequencing. She has also been recognized as a young talent in China’s Association for Science and Technology’s Talent Lifting Program, an acknowledgment of her potential and early career achievements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhang has published 19 SCI-indexed papers across reputable journals, such as GUT, Journal of Hepatology, Science Advances, and Molecular Therapy. Her research spans nephrology and single-cell sequencing, with a specific focus on applying multi-omics technology to understand disease development and progression. With 8 first-author papers and 5 co-corresponding author papers, she has become a leading voice in her field, contributing to groundbreaking insights in disease biology.

 📚 ACADEMIC CITES 

  • Dr. Zhang’s research excellence is reflected in multiple awards, including the Beijing Natural Science Award (second prize) and accolades for her dissertation work. She has also been named a Youth Member of the Smart Medical Professional Committee of the Chinese Association of Integrative Medicine, enhancing her profile as a respected thought leader in innovative medical research.

🌍 IMPACT AND INFLUENCE

  • Dr. Zhang’s work has garnered significant attention, with her research cited 850 times overall and her highest-cited paper receiving 360 citations. Notably, her contributions include 3 ESI highly cited papers and 1 F1000 recommended paper, underscoring her work’s influence within the scientific community. Her ability to address complex medical challenges has positioned her as a key contributor to both nephrology and integrative medical research.

🌟 LEGACY AND FUTURE AND CONTRIBUTIONS

  • Looking ahead, Dr. Zhang aims to deepen her contributions to nephrology through advanced, single-cell sequencing approaches and multi-omics studies. Her ongoing and completed research projects, including those funded by the National Natural Science Foundation of China (Grant No. 82203636) and the Young Talent Project of Chinese PLA General Hospital (20230403), highlight her commitment to tackling complex nephrological issues and contributing to the future of medical science.

📄Publications

  • “Comparison of preparation methods of rat kidney single-cell suspensions”
    Authors: Wang, T., Shen, W., Li, L., … Zhang, M., Chen, X.
    Journal: Scientific Reports, 2024, 14(1), 2785
  • “Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq”
    Authors: Tian, Y., Liu, C., Yang, W., … Qin, Y., Wu, S.
    Journal: Cancer Immunology, Immunotherapy, 2024, 73(10), 187
  • “Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer”
    Authors: Zhang, F., Li, T., Bai, Y., … Tao, H., Hu, Y.
    Journal: Journal of Translational Internal Medicine, 2024, 12(3), pp. 317–320
  • “Enhanced TRPC3 transcription through AT1R/PKA/CREB signaling contributes to mitochondrial dysfunction in renal tubular epithelial cells in D-galactose-induced accelerated aging mice”
    Authors: Wang, B., Yu, W., Zhang, W., … Chen, X., Chen, Y.
    Journal: Aging Cell, 2024, 23(6), e14130
  • “Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression”
    Authors: Chen, X., Wang, T., Chen, L., … Zhang, M., Chen, X.
    Journal: JCI Insight, 2024, 9(9), e173651
Min Zhang | Nephrology | Best Researcher Award